Kempinas W D, Suarez J D, Roberts N L, Strader L, Ferrell J, Goldman J M, Klinefelter G R
Departamento de Morfologia, Instituto de Biociências - UNESP, Botucatu, SP, Brazil.
Biol Reprod. 1998 Oct;59(4):890-6. doi: 10.1095/biolreprod59.4.890.
Guanethidine, a chemical that selectively abolishes peripheral noradrenergic nerves, was used to investigate the role of sympathetic innervation in the maintenance of epididymal sperm quantity and quality. Four groups of 10 adult male rats each were treated daily for 21 days, by i.p. injections, with either 0 (saline vehicle), 6.25, 12.5, or 25 mg/kg guanethidine. Norepinephrine content was reduced to undetectable levels in the cauda epididymidis in all guanethidine groups after 3 wk of treatment and was reduced to 7.4% of the control values after 1 wk of 6.25 mg/kg treatment. While body weight gain was significantly decreased at 12.5 and 25 mg/kg compared to that in controls, there was a significant increase in the weights of the seminal vesicles/coagulating glands in all treated groups. The number of homogenization-resistant spermatids per testis and the daily sperm production per testis remained unchanged. The weight of the epididymis was significantly increased at 6.25 and 12.5 mg/kg. Moreover, the number of cauda epididymal sperm and the transit time were increased significantly at 6.25 mg/kg (10.2 days) compared to values in the control cauda (6.3 days). Neither serum testosterone levels nor LH was affected in a dosage-related manner. There were no effects of guanethidine treatment on cauda epididymal sperm motility or morphology. A quantitative analysis of detergent-extracted cauda epididymal sperm proteins by SDS-PAGE revealed no differences, but there were diminutions in seven proteins in homogenates of caput/corpus tissue. Histologic analysis of testis and epididymis sections revealed no differences between control and denervated animals. In a subsequent experiment the lowest effective dosage (6.25 mg/kg) was given to rats for 1 wk, and an increased number of cauda epididymal sperm and a delay in sperm transit were observed. Our results indicate that low-dosage guanethidine exposure denervates the epididymis within 1 wk, thereby delaying epididymal transit; however, neither 1- nor 3-wk exposure produces qualitative changes in the sperm.
胍乙啶是一种能选择性消除外周去甲肾上腺素能神经的化学物质,被用于研究交感神经支配在维持附睾精子数量和质量方面的作用。将四组,每组10只成年雄性大鼠,通过腹腔注射,每天给予0(生理盐水载体)、6.25、12.5或25mg/kg胍乙啶,持续21天。治疗3周后,所有胍乙啶组附睾尾部的去甲肾上腺素含量降至检测不到的水平,6.25mg/kg治疗1周后降至对照值的7.4%。虽然与对照组相比,12.5和25mg/kg时体重增加显著降低,但所有治疗组的精囊/凝固腺重量均显著增加。每个睾丸中抗均质化精子细胞的数量和每个睾丸的每日精子产量保持不变。6.25和12.5mg/kg时附睾重量显著增加。此外,与对照附睾(6.3天)相比,6.25mg/kg(10.2天)时附睾尾部精子数量和转运时间显著增加。血清睾酮水平和促黄体生成素均未受到剂量相关的影响。胍乙啶治疗对附睾尾部精子活力或形态没有影响。通过SDS-PAGE对去污剂提取的附睾尾部精子蛋白进行定量分析,未发现差异,但在头/体组织匀浆中有7种蛋白减少。睾丸和附睾切片的组织学分析显示对照动物和去神经动物之间没有差异。在随后的实验中,将最低有效剂量(6.25mg/kg)给予大鼠1周,观察到附睾尾部精子数量增加和精子转运延迟。我们的结果表明,低剂量胍乙啶暴露在1周内使附睾去神经,从而延迟附睾转运;然而,1周或3周的暴露均未使精子产生质量变化。